medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2023, Number 3

<< Back Next >>

Sal Jal 2023; 10 (3)

Effect of the SARS-CoV-2 pandemic (COVID-19) on vector-borne diseases in Mexico

Godoy-Zendejas PS, Villa-Manzano AI, Robles-Cruz JA, Yáñez-Ortega R, Saldate-Meza YL

Language: Spanish
References: 15
Page: 134-137
PDF size: 161.73 Kb.


ABSTRACT

Introduction: during the pandemic, it should be considered that vector-borne diseases (VBD) and SARS-CoV-2 (COVID-19) have similarities in clinical presentation, which could have caused a delay in the diagnosis and spread of the virus. Material and methods: an ecological study was carried out. The national censuses (SINAVE database) of vector-borne diseases (dengue, chikungunya, zika and Chagas) in Mexico during the pre-pandemic period and during the COVID-19 pandemic were evaluated. Prevalences are compared with χ2 and the absolute risk reduction (ARR) of each VBD and cross-product ratio (OR) are calculated. Results: in this study we found the following prevalences 2019 vs 2020: dengue, 41,505 (0.032%) vs 24,313 (0.019%) OR = 0.59 (95% CI), p = 0.001 and ARR = 0.013%; chikungunya, 9 (0.0000070 %) vs 7 (0.0000055%) OR = 0.78, p = 0.0001 and ARR = 0.0000015%; zika, 138 (0.00010%) vs 20 (0.000015%) OR = 0.14, p = 0.001 and ARR = 0.000085%; Chagas, 889 (0.00069%) vs 391 (0.00031%) OR = 0.44, p = 0.001 and ARR = 0.00038%. VBD mortality, 191 (0.0000015%) vs 79 (0.00000063%) OR = 0.41, p = 0.001 and ARR = 0.00000087%. Conclusion: the COVID-19 pandemic in Mexico had an effect of underreporting, management, and treatment of vector-borne diseases, which should be avoided in future pandemic events.


REFERENCES

  1. Torres-Castro MA, Noh-Pech HR, Lugo-Caballero CI, Dzul-Rosado KR, Puerto FI. Las enfermedades transmitidas por vector: importancia y aspectos epidemiológicos. Bioagrociencias. 2020;13(1):31-41.

  2. Pagani Balletti R. Enfermedades epidémicas y pandémicas: causas, cronología e implicaciones socioculturales. An Real Acad Farm. 2020;86(3):189-213.

  3. Gurumendi España I, Calle Gómez M. Análisis de la relación Covid 19 y dengue dentro de la época de pandemia marzo a mayo en el Ecuador. Universidad Y Sociedad. 2020;12(S1):261-268.

  4. Lim JT, Dickens BSL, Chew LZX, Choo ELW, Koo JR, Aik J, et al. Impact of sars-cov-2 interventions on dengue transmission. PLoS Negl Trop Dis. 2020;14(10):e0008719. doi: 10.1371/journal.pntd.0008719.

  5. Álvarez-Lam I. Alerta en las Américas, infección por virus Zika. Rev Cubana Pediatr. 2016;88(4):403-404.

  6. Alvarado-Castroa VA, Ramírez-Hernández E, Paredes-Solís S, Legorreta Soberanis J, Saldana-Herrera VG, Salas-Francoa LS, et al. Caracterización clínica del dengue y variables predictoras de gravedad en pacientes pediátricos en un hospital de segundo nivel en Chilpancingo, Guerrero, México: serie de casos. Bol Med Hosp Infant Mex. 2016;73(4):237-242.

  7. Guía de Práctica Clínica GPC. Manejo del dengue no grave y el dengue grave. México: Secretaría de Salud de México. Disponible en: http://www.cenaprece.salud.gob.mx/programas/interior/vectores/descargas/pdf/SSA_151_08_GRR_Dengue_170610.pdf

  8. Secretaría de Salud. Diagnóstico diferencial dengue/ chikungunya/ virus zika. Nota descriptiva. 2016. Disponible en: http://cnts.salud.gob.mx/interior/DIAGNOSTICO_DIFERENCIAL_DENGUE_CHIKUNGUNYA_ZIKA.pdf

  9. Coronavirus disease 2019 (COVID-19). Situation report-26. 15 February 2020 [Internet]. Geneva, Switzerland: World Health Organization; 2020. Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200215-sitrep-26-covid-19.pdf?sfvrsn=a4cc6787_2

  10. Yan G, Lee CK, Lam LTM, Yan B, Chua YX, Lim AYN, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;20(5):536.

  11. Joob B, Wiwanitkit V. Hemorrhagic problem among the patients with COVID-19: clinical summary of 41 Thai infected patients. Clin Appl Thromb Hemost. 2020;26:1076029620918308.

  12. Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for Dengue. J Am Acad Dermatol. 2020;83(5):e177.

  13. Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40:823.

  14. Base de datos SINAVE, enfermedades transmitidas por vectores. Disponible en: https://www.sinave.gob.mx/

  15. Programa de acción: enfermedades transmitidas por vector. México: Secretaría de Salud; 2001. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/vectores.pdf




2020     |     www.medigraphic.com